JCA DEVELOPMENT OF MIAMI, INC. — TTAB Proceedings
JCA DEVELOPMENT OF MIAMI, INC. is a party to 8 TTAB proceedings.
Proceedings
- Proceeding 85023956 — Extensions of Time to Oppose, Terminated (filed 2010-10-06) against Bristol-Myers Squibb Company as defendant
- Proceeding 91191142 — Oppositions, Terminated (filed 2009-07-21) against Novartis AG as defendant
- Proceeding 91191154 — Oppositions, Terminated (filed 2009-07-21) against Clarins Groupe, S.a.r.l. as defendant
- Proceeding 91191190 — Oppositions, Terminated (filed 2009-07-22) against Schering Corporation as defendant
- Proceeding 91191188 — Oppositions, Terminated (filed 2009-07-22) against Barr Laboratories, Inc. as defendant
- Proceeding 77617496 — Extensions of Time to Oppose, Terminated (filed 2009-04-09) against Glaxo Group Limited as defendant
- Proceeding 77629620 — Extensions of Time to Oppose, Terminated (filed 2009-04-02) against Clarins Groupe, S.a.r.l. as defendant
- Proceeding 77258102 — Extensions of Time to Oppose, Terminated (filed 2008-03-19) against KOS LIFE SCIENCES LLC as defendant
Marks in These TTAB Matters
- ZENCIA — proceeding 85023956 (Defendant)
- CLARIS — proceeding 91191190 (Defendant)
- CLARIS — proceeding 91191188 (Defendant)
- CLARIS — proceeding 91191142 (Defendant)
- CLARIS — proceeding 91191154 (Defendant)
- CERISA — proceeding 77617496 (Defendant)
- CLARIS — proceeding 77629620 (Defendant)
- REMEVEN — proceeding 77258102 (Defendant)
Common TTAB Counterparties
- Clarins Groupe, S.a.r.l. — 2 proceedings
- Barr Laboratories, Inc. — 1 proceedings
- Bristol-Myers Squibb Company — 1 proceedings
- Glaxo Group Limited — 1 proceedings
- KOS LIFE SCIENCES LLC — 1 proceedings
- Novartis AG — 1 proceedings
- Schering Corporation — 1 proceedings
Recent TTAB Timeline
- 2011-01-19: 85023956 — EXTENSION OF TIME GRANTED involving Bristol-Myers Squibb Company
- 2011-01-19: 85023956 — INCOMING - EXT TIME TO OPPOSE FILED involving Bristol-Myers Squibb Company
- 2010-10-06: 85023956 — EXTENSION OF TIME GRANTED involving Bristol-Myers Squibb Company
- 2010-10-06: 85023956 — INCOMING - EXT TIME TO OPPOSE FILED involving Bristol-Myers Squibb Company
- 2009-11-18: 91191142 — TERMINATED involving Novartis AG
- 2009-11-18: 91191142 — BOARD'S DECISION: SUSTAINED involving Novartis AG
- 2009-11-16: 91191154 — TERMINATED involving Clarins Groupe, S.a.r.l.
- 2009-11-16: 91191154 — BOARD'S DECISION: SUSTAINED involving Clarins Groupe, S.a.r.l.
- 2009-11-12: 91191190 — TERMINATED involving Schering Corporation
- 2009-11-12: 91191190 — BOARD'S DECISION: SUSTAINED involving Schering Corporation
- 2009-11-12: 91191188 — TERMINATED involving Barr Laboratories, Inc.
- 2009-11-12: 91191188 — BOARD'S DECISION: SUSTAINED involving Barr Laboratories, Inc.
- 2009-11-09: 91191190 — WITHDRAWAL OF APPLICATION involving Schering Corporation
- 2009-11-05: 91191154 — SUBMITTED ON BRIEF involving Clarins Groupe, S.a.r.l.
- 2009-11-05: 91191142 — WITHDRAWAL OF APPLICATION involving Novartis AG
- 2009-11-05: 91191188 — WITHDRAWAL OF APPLICATION involving Barr Laboratories, Inc.
- 2009-10-05: 91191154 — SUBMITTED ON BRIEF involving Clarins Groupe, S.a.r.l.
- 2009-10-02: 91191142 — SUBMITTED ON BRIEF involving Novartis AG
- 2009-09-30: 91191154 — SUBMITTED ON BRIEF involving Clarins Groupe, S.a.r.l.
- 2009-09-29: 91191154 — SUBMITTED ON BRIEF involving Clarins Groupe, S.a.r.l.
- 2009-09-24: 91191142 — SUBMITTED ON BRIEF involving Novartis AG
- 2009-09-24: 91191154 — D RESP TO BD ORDER/INQUIRY involving Clarins Groupe, S.a.r.l.
- 2009-09-23: 91191154 — SUBMITTED ON BRIEF involving Clarins Groupe, S.a.r.l.
- 2009-09-21: 91191190 — ANSWER involving Schering Corporation
- 2009-09-21: 91191188 — ANSWER involving Barr Laboratories, Inc.
- 2009-09-18: 91191142 — SUBMITTED ON BRIEF involving Novartis AG
- 2009-09-18: 91191154 — ANSWER involving Clarins Groupe, S.a.r.l.
- 2009-09-18: 91191142 — SUBMITTED ON BRIEF involving Novartis AG
- 2009-09-17: 91191190 — SUBMITTED ON BRIEF involving Schering Corporation
- 2009-09-17: 91191188 — SUBMITTED ON BRIEF involving Barr Laboratories, Inc.